Literature DB >> 22976385

Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.

Santosh Rudrawar1, Philip S Kerry, Marie-Anne Rameix-Welti, Andrea Maggioni, Jeffrey C Dyason, Faith J Rose, Sylvie van der Werf, Robin J Thomson, Nadia Naffakh, Rupert J M Russell, Mark von Itzstein.   

Abstract

Novel 3-C-alkylated-Neu5Ac2en derivatives have been designed to target the expanded active site cavity of influenza virus sialidases with an open 150-loop, currently seen in X-ray crystal structures of influenza A virus group-1 (N1, N4, N5, N8), but not group-2 (N2, N9), sialidases. The compounds show selectivity for inhibition of H5N1 and pdm09 H1N1 sialidases over an N2 sialidase, providing evidence of the relative 150-loop flexibility of these sialidases. In a complex with N8 sialidase, the C3 substituent of 3-phenylally-Neu5Ac2en occupies the 150-cavity while the central ring and the remaining substituents bind the active site as seen for the unsubstituted template. This new class of inhibitors, which can 'trap' the open 150-loop form of the sialidase, should prove useful as probes of 150-loop flexibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976385     DOI: 10.1039/c2ob25627d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  7 in total

1.  Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Authors:  Wenwen Lian; Jiansong Fang; Chao Li; Xiaocong Pang; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2015-12-21       Impact factor: 2.943

2.  Structural basis for a class of nanomolar influenza A neuraminidase inhibitors.

Authors:  Philip S Kerry; Sankar Mohan; Rupert J M Russell; Nicole Bance; Masahiro Niikura; B Mario Pinto
Journal:  Sci Rep       Date:  2013-10-16       Impact factor: 4.379

3.  Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.

Authors:  L Ramírez-Salinas Gema; L E Tolentino-Lopez; F Martínez-Ramos; I Padilla-Martínez; J García-Machorro; J Correa-Basurto
Journal:  J Mol Model       Date:  2015-01-22       Impact factor: 1.810

4.  Direct access to various C3-substituted sialyl glycal derivatives from 3-iodo-sialyl glycals.

Authors:  Qingjiang Li; Jiatong Guo; Zhongwu Guo
Journal:  Org Biomol Chem       Date:  2021-12-01       Impact factor: 3.876

5.  Influenza A Virus Neuraminidase Inhibitors.

Authors:  Nongluk Sriwilaijaroen; Christopher J Vavricka; Hiromasa Kiyota; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2022

6.  Evolutionary and Mutational Characterization of the First H5N8 Subtype Influenza A Virus in Humans.

Authors:  Lin Ding; Jie Li; Xue Li; Bingqian Qu
Journal:  Pathogens       Date:  2022-06-08

Review 7.  New small-molecule drug design strategies for fighting resistant influenza A.

Authors:  Zuyuan Shen; Kaiyan Lou; Wei Wang
Journal:  Acta Pharm Sin B       Date:  2015-09-06       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.